Public disclosures

Nova Tina Susan

Company insiders · Director · EXAGEN INC.

Advertisement
FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-02.Following & alerts
Reported transaction lines
1
Buy lines
0
Sell lines
0

Filing activity by month

Original filing lines in up to 12 months with activity.

  • 2026-111

Frequently disclosed stocks

Disclosure history

More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSource
Nova Tina Susan

Director · EXAGEN INC.

XGN

EXAGEN INC.

Equity grant or award
Filing details

SEC transaction code A

Stock Option(right to buy) · Derivative security · Direct ownership · Reported balance after transaction: 137313 · The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

2026-06-092026-11-02

56,200 shares/units

SEC 4

Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.

Advertisement